Boundless Bio
BOLD
$4.43
Share price
-18.11%
Change (1 day)
N/A
Change (1 year)
Categories
Boundless Bio (BOLD) - Cash on Hand
Cash on Hand as of March 2024 : $0.10 B
According to Boundless Bio's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Boundless Bio - Cash on Hand chart (from 2022 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.12 B | 80.99% |
| 2022-12-31 | $66.71 M | -8.65% |
| 2021-12-31 | $73.03 M |